<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head>
<body>
<p>Hi everyone,</p>
<p>At our university (University of Nebraska), the university system
retains the copyright, but the investigator is free to set up
whatever license they want. I'm curious to see if there even is a
university (or their tech transfer office) that would dictate
which OS license the investigator should use.<br>
</p>
<p>Best,<br>
</p>
<div class="moz-signature">
<div style="line-height:16px; margin:6px 0; padding:8px 8px 8px
8px; border-top:1px #aeb1a6 dotted; border-bottom:1px #aeb1a6
dotted; font-face: Calibri, Verdana; font-size:11px;
color:grey;">
<font ;="" font-style="bold" size="2.5px;" color="#0049FF">Tomas
Helikar, Ph.D.</font> <br>
Associate Professor <br>
Department of Biochemistry | University of Nebraska-Lincoln <br>
m: <a href="callto:402-547-8904" style="color:rgb(0, 136, 204)
!important;">402-547-8904</a> | o: <a href="callto:402-472-3530" style="color:rgb(0, 136, 204)
!important;">402-472-3530</a><br>
<a href="http://www.postbox-inc.com" style="color:rgb(0, 136,
204) !important; text-decoration:none !important;
border-bottom:1px dotted #AAA;">www.helikarlab.org</a> | <a href="http://helikarlab.org" style="color:rgb(0, 136, 204)
!important; text-decoration:none !important; border-bottom:1px
dotted #AAA;">cellcollective.org</a><br>
twitter: <a href="http://twitter.com/helikarlab" style="color:rgb(0, 136, 204) !important; text-decoration:none
!important; border-bottom:1px dotted #AAA;">@helikarlab</a>, <a href="http://twitter.com/biocollective" style="color:rgb(0,
136, 204) !important; text-decoration:none !important;
border-bottom:1px dotted #AAA;">@biocollective</a>
</div>
</div>
<div class="moz-cite-prefix">On 1/26/21 3:52 AM, Robin Thompson
wrote:<br>
</div>
<blockquote type="cite" cite="mid:F1E73893-6F68-41F1-B871-378B14E892B9@gmail.com">
<div>
<font face="sans-serif" color="#FF6347">Non-NU Email</font>
<hr>
</div>
That sounds great, thanks both. I will let you know when I hear
back about Oxford’s policy on commercial use of IP. As above, all
authors are happy with this in principle (we are grateful that
others might want to use our models!)
<div class=""><br class="">
</div>
<div class="">Best wishes,</div>
<div class="">Robin</div>
<div class=""><br class="">
<div class="">
<div dir="auto" style="caret-color: rgb(0, 0, 0); color:
rgb(0, 0, 0); letter-spacing: normal; text-align: start;
text-indent: 0px; text-transform: none; white-space: normal;
word-spacing: 0px; -webkit-text-stroke-width: 0px;
text-decoration: none; word-wrap: break-word;
-webkit-nbsp-mode: space; line-break: after-white-space;" class="">
<div dir="auto" style="caret-color: rgb(0, 0, 0); color:
rgb(0, 0, 0); letter-spacing: normal; text-align: start;
text-indent: 0px; text-transform: none; white-space:
normal; word-spacing: 0px; -webkit-text-stroke-width: 0px;
text-decoration: none; word-wrap: break-word;
-webkit-nbsp-mode: space; line-break: after-white-space;" class="">
<div>----------------------------------------------------------------------<br class="">
Dr Robin Thompson<br class="">
Assistant Professor of Mathematical Epidemiology<br class="">
Mathematics Institute<br class="">
University of Warwick, UK<br class="">
<a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.robin-2Dthompson.co.uk&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=N3BoKaIVANlvX-Y4BnCQHSQxKYy32mZNJ2Q9_AwX9lg&e=" class="" moz-do-not-send="true">www.robin-thompson.co.uk</a><br class="">
----------------------------------------------------------------------</div>
</div>
</div>
</div>
<div><br class="">
<blockquote type="cite" class="">
<div class="">On 26 Jan 2021, at 00:47, Jacob Barhak <<a href="mailto:jacob.barhak@gmail.com" class="" moz-do-not-send="true">jacob.barhak@gmail.com</a>>
wrote:</div>
<br class="Apple-interchange-newline">
<div class="">
<div dir="ltr" class="">Yes Sheriff,<br class="">
<div class=""><br class="">
</div>
<div class="">This makes sense if Robin and his
co-authors want to invest more time to invest in the
archiving process - which I support. </div>
<div class="">However, the license issue needs to be
resolved first. You see, for anyone to release the
model into-biomodels they need to give away copyright
to release under CC0.</div>
<div class=""><br class="">
</div>
<div class="">And this is basically what I was asking -
what is the licensing policies the institution has?
For example, can the authors waive copyright in that
institution? </div>
<div class=""><br class="">
</div>
<div class="">If the answer is yes and I get permission,
I promise to upload a simplified version of one of
their models to Bio-Models - one that I have
implemented with the authors permission.</div>
<div class=""><br class="">
</div>
<div class="">This will be a nice example of what
should be done for models. However, this email thread
was intended to show the differences in approach for
licensing and float it up. Not all institutions allow
everything to creators - it varies and conditional on
many factors that may change. </div>
<div class=""><br class="">
</div>
<div class="">I hope it is possible.</div>
<div class=""><br class="">
</div>
<div class=""> Jacob</div>
<div class=""><br class="">
</div>
<div class=""><br class="">
</div>
<div class=""><br class="">
</div>
<div class=""><br class="">
</div>
</div>
<br class="">
<div class="gmail_quote">
<div dir="ltr" class="gmail_attr">On Mon, Jan 25, 2021
at 6:10 PM Rahuman Sheriff <<a href="mailto:sheriff@ebi.ac.uk" class="" moz-do-not-send="true">sheriff@ebi.ac.uk</a>>
wrote:<br class="">
</div>
<blockquote class="gmail_quote" style="margin:0px 0px
0px 0.8ex;border-left:1px solid
rgb(204,204,204);padding-left:1ex">
<div style="overflow-wrap: break-word;" class="">Dear
Robin and Jacob,
<div class="">I am happy to support, if you would
like the model to be deposited to BioModels
repository [1].</div>
<div class="">Not only the models gets higher
visibility, it might be potentially curated and
annotated and therefore can attract higher
citation.</div>
<div class=""><br class="">
</div>
<div class="">Best regards</div>
<div class="">Sheriff</div>
<div class=""><br class="">
</div>
<div class="">[1] <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__academic.oup.com_nar_article_48_D1_D407_5614569&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=QT4smRgJIXEaNNY8dtot9JqoHZHCMy6ZYNpNs6YvOaE&e=" target="_blank" class="" moz-do-not-send="true">https://academic.oup.com/nar/article/48/D1/D407/5614569</a><br class="">
<div class=""><br class="">
<blockquote type="cite" class="">
<div class="">On 24 Jan 2021, at 18:05, Robin
Thompson <<a href="mailto:robin.thompson1988@gmail.com" target="_blank" class="" moz-do-not-send="true">robin.thompson1988@gmail.com</a>>
wrote:</div>
<br class="">
<div class="">
<div style="overflow-wrap: break-word;" class="">Hi Jacob,
<div class=""><br class="">
</div>
<div class="">Thanks for your email. I
have asked the relevant person at Oxford
University (the institution I was at
when this research was undertaken), and
I will let you know when I hear back
from them.</div>
<div class=""><br class="">
</div>
<div class="">Thanks, and best wishes,</div>
<div class="">Robin</div>
<div class=""><br class="">
<div class="">
<div dir="auto" style="letter-spacing:normal;text-align:start;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px;text-decoration:none" class="">
<div dir="auto" style="letter-spacing:normal;text-align:start;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px;text-decoration:none" class="">
<div class="">----------------------------------------------------------------------<br class="">
Dr Robin Thompson<br class="">
Assistant Professor of
Mathematical Epidemiology<br class="">
Mathematics Institute<br class="">
University of Warwick, UK<br class="">
<a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.robin-2Dthompson.co.uk_&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=U2uKHMmBHfzYm_789nU7zyYRHmlTBaSAuEPF0wluqYo&e=" target="_blank" class="" moz-do-not-send="true">www.robin-thompson.co.uk</a><br class="">
----------------------------------------------------------------------</div>
</div>
</div>
</div>
<div class=""><br class="">
<blockquote type="cite" class="">
<div class="">On 22 Jan 2021, at
20:37, Jacob Barhak <<a href="mailto:jacob.barhak@gmail.com" target="_blank" class="" moz-do-not-send="true">jacob.barhak@gmail.com</a>>
wrote:</div>
<br class="">
<div class="">
<div dir="ltr" class="">Hi Robin,
and anyone else who wants to
comment,
<div class="">
<div class=""><br class="">
</div>
<div class="">When integrating
your model, you may recall I
asked for permissions to use
it and mentioned licensing
issues.</div>
<div class=""><br class="">
</div>
<div class="">One of your
responses was that you have
to check with your
institution regarding
commercial use while you
yourself were ok with me
reusing your model and had
no restrictions.</div>
<div class=""><br class="">
</div>
<div class="">I wish to
explore the licensing issue
in this mailing list to show
what are approaches of
different institutions and
individuals to the problem.</div>
<div class=""><br class="">
</div>
<div class="">Is it possible
for you to check about the
policy in your institution?
The idea is to show some
examples of how institutions
approach the issue. For
example, do they delegate
the decision to researchers?
Do they have a policy about
who holds the copyright? How
do they treat
commercial entities?</div>
<div class=""><br class="">
</div>
<div class="">I know in the
US, a faculty member in most
cases retains rights for
their work, this does not
always extend to staff and I
am not sure about students.
I also know that some
academic institutions
support tech transfer
through patents and other
endeavours. </div>
<div class=""><br class="">
</div>
<div class="">I was trying to
discuss licenses here:</div>
<div class=""><a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__forum.comses.net_t_issues-2Dwith-2Dregard-2Dto-2Dcall-2Dfor-2Dtransparency-2Dof-2Dcovid-2D19-2Dmodels_8433&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=gH5csg3_h8RTAcz5uHrxGVuUx-7fyJTy-Xmq956sPAA&e=" target="_blank" class="" moz-do-not-send="true">https://forum.comses.net/t/issues-with-regard-to-call-for-transparency-of-covid-19-models/8433</a> </div>
<div class=""><br class="">
</div>
<div class="">Yet this
discussion was not
concluded. </div>
<div class=""><br class="">
</div>
<div class="">One notable
approach that Sheriff made
me aware of is taken by
BioModels:</div>
<div class=""><a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ebi.ac.uk_biomodels_faq&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=KS6kRQBfSpa4lpZQ01NJ73yFXAOeIisbWFDK911tRl8&e=" target="_blank" class="" moz-do-not-send="true">http://www.ebi.ac.uk/biomodels/faq</a><br class="">
</div>
<div class="">They avoid the
licensing issues by making
all models available under
CC0</div>
<div class=""><br class="">
</div>
<div class="">I am showing
here some aspects of the
issue and asking for you to
check with your institution
to explore all aspects of
this issue so we can
properly report those in the
white paper.</div>
<div class=""><br class="">
</div>
<div class=""> Jacob</div>
<div class=""><br class="">
</div>
<div class=""><br class="">
</div>
<div class=""><br class="">
</div>
<div class=""><br class="">
</div>
<div class=""><br class="">
</div>
</div>
</div>
</div>
</blockquote>
</div>
<br class="">
</div>
</div>
</div>
</blockquote>
</div>
<br class="">
</div>
</div>
</blockquote>
</div>
</div>
</blockquote>
</div>
<br class="">
</div>
<br>
<fieldset class="mimeAttachmentHeader"></fieldset>
<pre class="moz-quote-pre" wrap="">_______________________________________________
Vp-integration-subgroup mailing list
<a class="moz-txt-link-abbreviated" href="mailto:Vp-integration-subgroup@lists.simtk.org">Vp-integration-subgroup@lists.simtk.org</a>
<a class="moz-txt-link-freetext" href="https://urldefense.proofpoint.com/v2/url?u=https-3A__lists.simtk.org_mailman_listinfo_vp-2Dintegration-2Dsubgroup&d=DwIGaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=Ggyyr1Kd_CVAhkGxQBR9Svztrg7TawjjebCjTdXX_sE&e=">https://urldefense.proofpoint.com/v2/url?u=https-3A__lists.simtk.org_mailman_listinfo_vp-2Dintegration-2Dsubgroup&d=DwIGaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=-Yw1BpFxFm-_p8faDgx1YrsNo8j6cSOXM9OBk7XqvJk&s=Ggyyr1Kd_CVAhkGxQBR9Svztrg7TawjjebCjTdXX_sE&e=</a>
</pre>
</blockquote>
</body>
</html>